According to a report in Fierce Medical Devices, the trial court has upheld the 2 million verdict in the Donna Cisson v. C.R. Bard, Inc. transvaginal trial. Judge Joseph Goodwin reaffirmed that the initial award was appropriate and that attorneys representing Donna...
Drug and Medical Device Litigation
Drugs, Advertising, and Risks Associated with Direct to Consumer Ads
If you have watched a news program, sporting event, or network television show recently you have seen multiple ads for drugs or devices that will change your life. Whether it is “Larry the cable guy” for the “purple” pill, a handsome athletic looking couple looking...
Boston Scientific Settles Guidant Heart Devices Allegations for $30 Million
Boston Scientific Inc., already embroiled in transvaginal mesh litigation, agreed to pay $30 million stemming from claims that they knowingly sold defective heart devices that were implanted in Medicare patients. Boston Scientific acquired Guidant in 2006 and bought...
Why Are Drugs More Expensive in U.S. than in Other Countries?
Across America and throughout the world people with the same condition take the same drugs. However, the prices vary greatly. Take asthma, which affects 40 million Americans and countless millions throughout the world and is estimated by the Center for Disease...
Bloomberg Reports Settlement Talks in Mesh Cases
Bloomberg is reporting that C.R. Bard, Endo Health Solutions, Boston Scientific, Cook, and Coloplast are in what Judge Goodwin described a “behind the scenes” settlement talks. Johnson and Johnson (J&J) is reportedly NOT participating. Bard was held liable in two...
Another Plaintiffs Actos verdict, Another Verdict Thrown Out by Trial Judge
On September 26, 2013, a jury in Baltimore, Maryland, found that Takeda Pharmaceutical Co. did not properly warn Diep An, an ex-U.S. Army translator, and his doctor about the risks of its Actos diabetes drug and ordered the company to pay more than $1.7 million in...
California Supreme Court Victory for Generic Fosamax Users
On September 25, 2013, the California Supreme Court denied the generic Fosamax manufacturers petition for review thereby upholding the June 13, 2013 Court of Appeal decision allowing people injured by generic Fosamax to go forward in the Courts and hold the generic...
DePuy September 23, 2013 Bellwether Trial Continued
On September 20, the Honorable David Katz presiding over the DePuy bellwether case, Ann McCracken v. DePuy Orthopaedics, Inc., et. al., Case No. 11 dp 20485, continued the trial 90 days from September 24, 2013 “in the interest of justice”. According to the Order, the...
Bard Settles Another Vaginal Mesh Suit
On September 13, 2013, Bard settled Melanie Virgil’s claims that Bard’s Avaulta Plus insert caused urinary problems. The case, Virgil v. C.R. Bard Inc. (BCR), ATL-L6917-10, Superior Court of New Jersey Law Division, Atlantic County (Atlantic City), was scheduled to...
Second Actos Trial Begins
Lawyers for the family of Diep An told a Baltimore jury that drug giant Takeda’s failure to tell the whole truth about Actos role in the increased risk of cancer was the cause of death, as opening statements got under way. This case will provide further insight into...